Apoptosis and vascular wall remodeling in hypertension

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 7, 1996, Pages 850-861

  Hamet, Pavel ^a   DeBlois, Denis ^a   Dam, Than Vinh ^a   Richard, Lucie ^a   Teiger, Emmanuel ^a   Tea, Bun Seng ^a   Orlov, Sergei N ^a   Tremblay, Johanne ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Hypertension; Vascular smooth muscle cells

Indexed keywords

APOPTOSIS; BLOOD VESSEL WALL; CELL DIVISION; CONFERENCE PAPER; HUMAN; HYPERTENSION; MORPHOGENESIS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030451503     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y96-076     Document Type: Conference Paper

References (91)

1. Bennett, M.R., Evan, G.I., and Newby, A.C. 1994. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-τ, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ. Res. 74: 525-536.
2. Bennett, M.R., Evan, G.I., and Schwartz, S.M. 1995a. Apoptosis of rat vascular smooth muscle cells is regulated by p53 dependent and independent pathways. Circ. Res. 77: 266-273.
3. Bennett, M.R., Evan, G.I., and Schwartz, S.M. 1995b. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95: 2266-2274.
4. Bennett, M.R., Gibson, D.F., Schwartz, S.M., and Tait, J.F. 1995c. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ. Res. 77(6): 1136-1142.
5. Bila, V., and Kren, V. 1989. The significance of genetic factors for thalidomide teratogenicity in the Norway rat. Acta Univ. Carol. (Med.) Praha, 351(2): 3-10.
6. Bochaton-Piallat, M.L., Gabbiani, F., Redard, M., Desmoulière, A., and Gabbiani, G. 1995. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am. J. Pathol. 146: 1059-1064.
7. Bondjers, G., Glukhova, M., Hansson, G.K., Postnov, Y.V., Reidy, M.A., and Schwartz, S.M. 1991. Hypertension and atherosclerosis. Cause and effect, or two effects with one unknown cause? Circulation, 84(Suppl. 6): V12-V16.
8. Bortner, C.D., Oldenburg, N.B.E., and Cidlowski, J.A. 1995. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 5: 21-26.
9. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164.
10. Burton, K. 1956. Study of conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62: 315-323.
11. Chinnaiyan, A.M., Orth, K., Orourke, K., Duan, H.J., Poirier, G.G., and Dixit, V.M. 1996. Molecular ordering of the cell death pathway BCL-2 and BCL-X(L) function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 1: 4573-4576.
12. Cho, A., Courtman, D.W., and Langille, B.L. 1995. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ. Res. 76: 168-175.
13. Clowes, A.W., Reidy, M.A., and Clowes, M.M. 1983. Kinetics of cellular proliferation after arterial injury. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49: 327-333.
14. Dam, T.V., Richard, L., Gossard, F., Tremblay, J., and Hamet, P. 1993. Visualization of apoptosis in organs by in situ labelling of DNA fragments. Adv. Gene Technol. 4: 42.
15. Darmon, A.J., Nicholson, D.W., and Bleackley, R.C. 1995. Activation of the apoptotic protease CPP32 by cytotoxic cell-derived granzyme B. Nature (London), 377: 446-448.
16. de Murcia, G., Jacobson, M., and Shall, S. 1995. Regulation by ADP-ribosylation. Trends Cell Biol. 5: 78-81.
17. El Alaoui, S., Mian, S., Lawry, J., Quash, G., and Griffin, M. 1992. Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis). FEBS Lett. 311(2): 174-178.
18. Evan, G.I., and Littlewood, T.D. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3(1): 44-49.
19. Filippovich, I., Sorokina, N., Khanna, K.K., and Lavin, M.F. 1994. Butyrate induced apoptosis in lymphoid cells preceded by transient overexpression of HSP70 mRNA. Biochem. Biophys. Res. Commun. 198: 257-265.
20. Folkow, B. 1982. Physiological aspects of primary hypertension. Physiol. Rev. 62: 347-504.
21. Folkow, B., Grimby, G., and Thulesius, O. 1957. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol. Scand. 44: 255-272.
22. Fukuo, K., Nakahashi, T., Hata, S., Morimoto, S., and Ogihara, T. 1996. Nitric oxide induces upregulation of Fas antigen and apoptosis in vascular smooth muscle cells. Hypertension (Dallas), 27: 823-826.
23. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119(3): 493-501.
24. Geng, Y.J., and Libby, P. 1995. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme. Am. J. Pathol. 147: 251-266.
25. Gold, R., Schmied, M., Giegerich, G., Breitschopf, H., Harung, H.P., Toyka, K.V., and Lassmann, H. 1994. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71(2): 219-225.
26. Hadrava, V., Tremblay, J., and Hamet, P. 1989. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension (Dallas), 13: 589-597.
27. Hamet, P. 1995. Proliferation and apoptosis in hypertension. Curr. Opin. Nephrol. Hypertens. 4: 1-7.
28. Hamet, P., Hadrava, V., Kruppa, U., and Tremblay, J. 1988. Vascular smooth muscle cell hyper-responsiveness to growth factors in hypertension. J. Hypertens. 6(Suppl. 4): S36-S39.
29. 1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats. Hypertension (Dallas), 17: 896-901.
30. Hamet, P., Richard, L., Dam, T.V., Teiger, E., Orlov, S.N., Gaboury, L., Gossard, F., and Tremblay, J. 1995. Apoptosis in target organs of hypertension. Hypertension (Dallas), 26: 642-648.
31. Han, D.K., Haudenschild, C.C., Hong, M.K., Tinkle, B.T., Leon, M.B., and Liau, G. 1995. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147: 267-277.
32. Hansen-Smith, F., Greene, A.S., Cowley, A.W., Jr., and Lombard, J.H. 1990. Structural changes during microvascular rarefaction in chronic hypertension. Hypertension (Dallas), 15(6): 922-928.
33. Hase, M., Araki, S., Kaji, K., and Hayashi, H. 1994. Classification of signals for blocking apoptosis in vascular endothelial cells. J. Biochem. 116: 905-909.
34. Heagerty, A.M., Aalkjaer, C., Bund, S.J., Korsgaard, N., and Mulvany, M.J. 1993. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension (Dallas), 21: 391-397.
35. Heistad, D.D., Armstrong, M.L., Baumbach, G.L., and Faraci, F.M. 1995. Sick vessel syndrome. Recovery of atherosclerotic and hypertensive vessels. Hypertension (Dallas), 26(3): 509-513.
36. Isner, J.M., Kearney, M., Bortman, S., and Passeri, J. 1995. Apoptosis in human atherosclerosis and restenosis. Circulation, 91(1): 2703-2711.
37. Jackson, C.L., and Schwartz, S.M. 1992. Pharmacology of smooth muscle cell replication. Hypertension (Dallas), 20: 713-736.
38. Jacobson, M.D., Burne, J. F., and Raff, M.C. 1994. Programmed cell death and bcl-2 protection in the absence of a nucleus. EMBO J. 13(8): 1899-1910.
39. James, T.N. 1994. Normal and abnormal consequences of apoptosis in the human heart. Circulation, 90: 556-573.
40. Kajstura, J., Mansukhani, M., Cheng, W., Reiss, K., Krajewski, S., Reed, J.C., Quaini, F., Sonnenblick, E.H., and Anversa, P. 1995. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp. Cell Res. 219: 110-121.
41. Katayose, D., Wersto, R., Cowan, K., and Seth, P. 1995. Consequences of p53 gene expression by adenovirus vector on cell cycle arrest and apoptosis in human aortic vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 215(2): 446-451.
42. Kaufmann, S.H., Desnoyers, S., Ottaviano, Y., Davidson, N.E., and Poirier, G.G. 1993. Specific proteolytic cleavage of poly (ADR-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53: 3976-3985.
43. Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257.
44. Klassen, N.V., Walker, P.R., Ross, C.K., Cygler, J., and Lach, B. 1993. Two-stage cell shrinkage and the OER for radiation-induced apoptosis of rat thymocytes. Int. J. Radiat. Biol. 64: 571-581.
45. Kockx, M.M., Cambier, B.A., Bortier, H.E., De Meyer, G.R., Declercq, S.C., van Cauwelaert, P.A., and Bultinck, J. 1994. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology, 25: 365-371.
46. Kunes, J., Pang, S.C., Cantin, M., Genest, J., and Hamet, P. 1987. Cardiac and renal hyperplasia in newborn spontaneously hypertensive rats. Clin. Sci. 72: 271-275.
47. Lacronique, V., Mignon, A., Fabre, M., Viollet, B., Rouquet, N., Molina, T., Porteu, A., Henrion, A., Bouscary, D., Varlet, P., Joulin, V., and Kahn, A. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-fas antibody in mice. Nature Med. 2(1): 80-86.
48. Lazebnik, Y.A., Kaufmann, S.H., Desnoyers, S., Poirier, G.G., and Earnshaw, W.C. 1994. Cleavage of poly(ADR-ribose) polymerase by a proteinase with properties like ICE. Nature (London), 371: 346-347.
49. Lee, R.M.K.W., and Smeda, J.S. 1985. Primary versus secondary structural changes of the blood vessels in hypertension. Can. J. Physiol. Pharmacol. 63: 392-401.
50. Leszczynski, D., Shao, Y., Luokkamaki, M., and Foegh, M.L. 1994. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in nontransformed rat vascular smooth muscle cells. Am. J. Pathol. 145: 1265-1270.
51. Libby, P., Warner, S.J., and Friedman, G.B. 1988. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growh-inhibitory prostanoids. J. Clin. Invest. 81: 487-498.
52. Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., Ikeda, J.E., MacKenzie, A., and Korneluk, R.G. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature (London), 379: 349-353.
53. Luscher, T.F. 1993. 1993 Mack Forster Award Lecture. Review. The endothelium as a target and mediator of cardiovascular disease. Eur. J. Clin. Invest. 23(11): 670-685.
54. Mailhos, C., Howard, M.K., and Latchman, D.S. 1993. Heat shock protects neuronal cells from programmed cell death by apoptosis. Neuroscience, 55: 621-627.
55. Majno, G., and Joris, I. 1995. Apoptosis, oncosis and necrosis. An overview of cell death. Am. J. Pathol. 146: 3-15.
56. McConkey, D.J., and Orrenius, S. 1994. Signal transduction pathways to apoptosis. Trends Cell Biol. 4: 370-375.
57. Meredith, J.E., Jr., Fazeli, B., and Schwartz, M.A. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell, 4: 953-961.
58. Migliorati, G., Nicoletti, I., Crocicchio, F., Pagliacci, C., Adamio, F.D., and Ricardi, C. 1992. Heat shock induces apoptosis in mouse thymocytes and protects them from glucocorticoid-induced cell death. Cell. Immunol. 143: 348-356.
59. Miura, M., Shu, H., Rotello, R., Hartwieg, E.A., and Yuan, J. 1993. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75(4): 653-660.
60. Nagata, S., and Golstein, P. 1995. The fas death factor. Science (Washington, D.C.), 267: 1449-1456.
61. 1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. U.S.A. 92: 10 663-10 667.
62. Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., King, C.K., Gallant, M., Gareau, Y., Friffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, N.A., Raju, S.M., Smulson, M.E., Yamin, T.T., Yu, V.L., and Miller, D.K. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (London), 376: 37-43.
63. Nunez, G., and Clarke, M.F. 1994. The bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol. 4: 399-403.
64. Oberhammer, F., Wilson, J.W., Dive, C., Morris, I.D., Kichman, J.A., Wakeling, A.E., Walker, P.R., and Sikorska, M. 1993. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12(9): 3679-3684.
65. Orlov, S.N., Dam, T.V., Tremblay, J., and Hamet, P. 1996. Apoptosis in vascular smooth muscle cells: role of cell shrinkage. Biochem. Biophys. Res. Commun. 221: 708-715.
66. Owens, G.K. 1989. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am. J. Physiol. 257(6, Part 2): H1755-H1765.
67. Pang, S.C., Long, C., Poirier, M., Tremblay, J., Kunes, J., Vincent, M., Sassard, J., Duzzi, L., Bianchi, G., Ledingham, J., Phelan, E.L., Simpson, F.O., Ikeda, K., Yamori, Y., and Hamet, P. 1986. Cardiac and renal hyperplasia in newborn genetically hypertensive rats. J. Hypertens. 4(Suppl. 3): S119-S122.
68. Paquet, J.L., Baudouin-Legros, M., Marche, P., and Meyer, P. 1989. Enhanced proliferating activity of cultured smooth muscle cells from SHR. Am. J. Hypertens. 2: 108-110.
69. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London), 362(6423): 801-809.
70. Salomon, R.N., and Diaz-Cano, S. 1995. Introduction to apoptosis. Diagn. Mol. Pathol. 4: 235-238.
71. Schiffrin, E.L. 1992. Reactivity of small blood vessels in hypertension: relation with structural changes. Hypertension (Dallas), 19(Suppl. II): II-1-II-9.
72. Schiffrin, E.L., Deng, L.Y., and Larochelle, P. 1995. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a β-blocker. Am. J. Hypertens. 8: 229-236.
73. Schlegel, J., Peters, I., Orrenius, S., Miller, D.K., Thornberry, N.A., Yamin, T.T., and Nicholson, D.W. 1996. CPP32 apopain is a key interleukin 1-β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271: 1841-1844.
74. Schumer, M., Colombel, M.C., Sawczuk, I.S., Gobe, G., Connor, J., O'Toole, K.M., Olsson, C.A., Wise, G.J., and Buttyan, R. 1992. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am. J. Pathol. 140: 831-838.
75. Schwartz, S.M., deBlois, D., and O'Brien, E.R. 1995. The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77: 445-465.
76. Scott-Burden, T., Resink, T.J., Baur, U., Burgin, M., and Buhler, F.R. 1989. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension (Dallas), 13: 295-304.
77. Speir, E., Modali, R., Huang, E.S., Leon, M.B., Shawl, F., Finkel, T., and Epstein, S.E. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (Washington, D.C.), 265(5170): 391-394.
78. Tanaka, M., Ito, H., Adachi, S., Akimoto, H., Nishikawa, T., Kasajima, T., Marumo, F., and Hiroe, M. 1994. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 75: 426-433.
79. Tanaka, M., Ohnishi, J., Ozawa, Y., Sugimoto, M., Usuki, S., Naruse, M., Murakami, K., and Miyazaki, H. 1995. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem. Biophys. Res. Commun. 207(2): 593-598.
80. Teiger, E., Dam, T.V., Richard, L., Wisnewsky, C., Tea, B.S., Gaboury, L., Tremblay, J., Schwartz, K., and Hamet, P. 1996. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97: 2891-2897.
81. Tewari, M., Quan, L.T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D.R., Poirier, G.G., Salvesen, G.S., and Dixit, V.M. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809.
82. Thompson, G.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science (Washington, D.C.), 267: 1456-1462.
83. Thybo, N.K., Stephens, N., Cooper, A., Aalkjaer, C., Heagerty, A.M., and Mulvany, M.J. 1995. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension (Dallas), 25(4): 474-481.
84. Vaux, D.L., Haecker, G., and Strasser, A. 1994. An evolutionary perspective on apoptosis. Cell, 76: 777-779.
85. Walter, S.V., and Hamet, P. 1986. Enhanced DNA synthesis in heart and kidney of newborn spontaneously hypertensive rats. Hypertension (Dallas), 8: 520-525.
86. Wang, L., Miura, M., Bergeron, L., Zhu, H., and Yuan, J. 1994. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell, 78: 739-750.
87. Warner, S.J.C., and Libby, P. 1989. Human vascular smooth muscle cells - target for and source of tumor necrosis factor. J. Immunol. 142: 100-109.
88. Whitacre, C.M., Hashimoto, H., Tsai, M.L., Chatterjee, S., Berger, S.J., and Berger, N.A. 1995. Involvement of NAD-poly (ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 55(17): 3697-3701.
89. Woo, D. 1995. Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 333: 18-25.
90. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London), 284: 555-556.
91. Yamada, T., Horiuchi, M., and Dzau, V.J. 1996. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 93: 156-160.